These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8085069)

  • 1. [Hepatotoxicity induced by valproic acid in adults. Report of 3 cases].
    Galdames D; Silva C; Aguilera L; Chesta J
    Rev Med Chil; 1993 Dec; 121(12):1432-6. PubMed ID: 8085069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute fatal liver insufficiency due to valproic acid therapy].
    Binek J; Hany A; Egloff B; Heer M
    Schweiz Med Wochenschr; 1991 Feb; 121(7):228-33. PubMed ID: 2008603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.
    Koenig SA; Buesing D; Longin E; Oehring R; Häussermann P; Kluger G; Lindmayer F; Hanusch R; Degen I; Kuhn H; Samii K; Jungck A; Brückner R; Seitz R; Boxtermann W; Weber Y; Knapp R; Richard HH; Weidner B; Kasper JM; Haensch CA; Fitzek S; Hartmann M; Borusiak P; Müller-Deile A; Degenhardt V; Korenke GC; Hoppen T; Specht U; Gerstner T
    Epilepsia; 2006 Dec; 47(12):2027-31. PubMed ID: 17201699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase.
    Star K; Edwards IR; Choonara I
    PLoS One; 2014; 9(10):e108970. PubMed ID: 25302991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high doses].
    Ghozzi H; Hakim A; Sahnoun Z; Ben Mahmoud L; Atheymen R; Hammami S; Zeghal K
    Rev Neurol (Paris); 2011; 167(8-9):600-6. PubMed ID: 21492891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic-acid-induced pancreatitis. Case report and review of the literature.
    Binek J; Hany A; Heer M
    J Clin Gastroenterol; 1991 Dec; 13(6):690-3. PubMed ID: 1761843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate hepatotoxicity: a review and report of two instances in adults.
    Dickinson RG; Bassett ML; Searle J; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1985; 21():79-91. PubMed ID: 3939614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatic failure associated with valproic acid in children. Report of 3 cases].
    Antoniuk SA; Bruck I; Hönnicke LR; Martins LT; Carreiro JE; Cat R
    Arq Neuropsiquiatr; 1996 Dec; 54(4):652-4. PubMed ID: 9201347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
    Felker D; Lynn A; Wang S; Johnson DE
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):211-8. PubMed ID: 24450420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thinking beyond the obvious: hepatotoxicity secondary to idiosyncratic depakote toxicity.
    Chaudrey KH; Naser TB; Steinberg A; Avashia KD; Nouri-Kolouri M; Asadi S; Irshad Khan SI; Ihsan M
    Am J Ther; 2012 Nov; 19(6):403-6. PubMed ID: 21248613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid hepatic fatalities. III. U.S. experience since 1986.
    Bryant AE; Dreifuss FE
    Neurology; 1996 Feb; 46(2):465-9. PubMed ID: 8614514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate metabolites and hepatotoxicity in an epileptic population.
    Tennison MB; Miles MV; Pollack GM; Thorn MD; Dupuis RE
    Epilepsia; 1988; 29(5):543-7. PubMed ID: 3137018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism.
    Kondo T; Kaneko S; Otani K; Ishida M; Hirano T; Fukushima Y; Muranaka H; Koide N; Yokoyama M
    Epilepsia; 1992; 33(1):172-7. PubMed ID: 1733753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal hepatotoxicity in child on phenobarbitone and sodium valproate.
    Jacobi G; Thorbeck R; Ritz A; Janssen W; Schmidts HL
    Lancet; 1980 Mar; 1(8170):712-3. PubMed ID: 6103126
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic acid hepatic fatalities: a retrospective review.
    Dreifuss FE; Santilli N; Langer DH; Sweeney KP; Moline KA; Menander KB
    Neurology; 1987 Mar; 37(3):379-85. PubMed ID: 3102998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological case of the month: sudden death in a child as a result of pancreatitis during valproic acid therapy.
    Mileusnic D; Donoghue ER; Lifschultz BD
    Pediatr Pathol Mol Med; 2002; 21(5):477-84. PubMed ID: 12396903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.